Pemetrexed Sandoz conc. 100 mg/4 ml
Pemetrexed Sandoz conc. 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 66501. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 July 2018 and the authorisation is valid without a time limit. ATC code L01BA04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 66501 |
|---|---|
| Name | Pemetrexed Sandoz conc. 100 mg/4 ml |
| Full name | Pemetrexed Sandoz conc. 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BA04 |
| First authorisation | 17 July 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pemetrexed Sandoz conc. 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 17 July 2018 |
| 2 | Pemetrexed Sandoz conc. 500 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 17 July 2018 |
| 3 | Pemetrexed Sandoz conc. 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 17 July 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 2 | 5 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 3 | 1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 4 | 5x1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 5 | 1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
| 6 | 5x1 | Durchstechflasche(n) | L01BA04 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pemetrexed Sandoz conc. 100 mg/4 ml authorised in Switzerland?
Yes. Pemetrexed Sandoz conc. 100 mg/4 ml is authorised by Swissmedic under authorisation number 66501, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pemetrexed Sandoz conc. 100 mg/4 ml have?
Pemetrexed Sandoz conc. 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pemetrexed Sandoz conc. 100 mg/4 ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.